Filing Details

Accession Number:
0001209191-20-034676
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-05 16:05:13
Reporting Period:
2020-06-03
Accepted Time:
2020-06-05 16:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1348587 L Patricia Allen C/o Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-03 6,365 $25.73 6,365 No 4 M Direct
Common Stock Disposition 2020-06-03 6,365 $59.14 0 No 4 S Direct
Common Stock Acquisiton 2020-06-05 5,635 $25.73 5,635 No 4 M Direct
Common Stock Disposition 2020-06-05 5,635 $55.90 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-06-03 6,365 $0.00 6,365 $25.73
Common Stock Stock Option (Right to Buy) Disposition 2020-06-05 5,635 $0.00 5,635 $25.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,635 2028-05-16 No 4 M Direct
0 2028-05-16 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.34, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.09 to $56.00, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. This stock option award was issued pursuant to Issuer's 2017 Stock Option and Incentive Plan and vested in full on May 17, 2019, subject to the Reporting Person's continuous service with the Issuer.